Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Reviewing Material Release or Rejection Decisions from Quarantine – V 2.0

Posted on By

SOP for Reviewing Material Release or Rejection Decisions from Quarantine – V 2.0

Standard Operating Procedure for Reviewing Material Release or Rejection Decisions from Quarantine

Department Quality Assurance / Quality Control / Warehouse
SOP No. SOP/RM/089/2025
Supersedes SOP/RM/089/2022
Page No. Page 1 of 15
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

This Standard Operating Procedure (SOP) defines the process for reviewing and approving decisions related to the release or rejection of raw materials from quarantine. It ensures that decisions are based on validated test results, regulatory compliance, and quality standards.

2. Scope

This SOP applies to all raw materials stored in quarantine, including Active Pharmaceutical Ingredients (APIs), excipients, solvents, and packaging materials, ensuring their proper release for use in manufacturing or rejection for disposal.

3. Responsibilities

  • Quality Assurance (QA): Review test results, verify compliance with specifications, and approve or reject materials.
  • Quality Control (QC): Conduct necessary tests on quarantined materials and document results accurately.
  • Warehouse Personnel: Ensure proper labeling and segregation of materials awaiting release or rejection decisions.

4. Accountability

The QA Manager is accountable for ensuring that all material release and rejection decisions comply with regulatory standards and company procedures. The QC Manager is responsible for providing

accurate test data to support these decisions.

5. Procedure

5.1 Initial Review of Test Results

  1. Collection of Test Results:
    • QC personnel conduct all required tests on quarantined materials and document results in the QC Test Result Log (Annexure-1).
    • Results must be reviewed for accuracy and completeness before submission to QA.
  2. Preliminary Assessment by QA:
    • QA reviews test results for conformance with material specifications.
    • Any discrepancies or out-of-specification (OOS) results must be documented and investigated (Annexure-2).
See also  SOP for Use of Safety Equipment While Handling Quarantined Chemicals - V 2.0

5.2 Criteria for Material Release

  1. Conformance to Specifications:
    • Materials must meet all physical, chemical, and microbiological specifications as per the approved material specification document.
  2. Regulatory Compliance:
    • Ensure that the material complies with applicable regulatory guidelines, such as ICH, WHO, and local regulatory authorities.
  3. Documentation Verification:
    • Verify that all required documents, including Certificates of Analysis (CoA), Material Safety Data Sheets (MSDS), and supplier certificates, are complete and accurate.
  4. Approval of Release:
    • QA signs off on the Material Release Authorization Form (Annexure-3).
    • Update the Quarantine Release Log with the release decision (Annexure-4).

5.3 Criteria for Material Rejection

  1. Non-Conformance to Specifications:
    • Materials that fail to meet specified criteria in any test parameter will be rejected.
  2. Contamination or Damage:
    • Materials showing signs of contamination, physical damage, or tampering will be rejected.
  3. Incomplete Documentation:
    • Materials without proper documentation, including missing CoA or MSDS, will not be released and may be rejected.
  4. Approval of Rejection:
    • QA documents the rejection decision in the Material Rejection Authorization Form (Annexure-5).
    • Update the Quarantine Rejection Log with the rejection decision (Annexure-6).

5.4 Investigation of Out-of-Specification (OOS) Results

  1. Identification and Documentation:
    • All OOS results must be documented in the OOS Report (Annexure-2).
  2. Root Cause Analysis:
    • Conduct a thorough investigation to determine the cause of the OOS result, including re-testing if applicable.
    • Document the investigation in the OOS Investigation Report (Annexure-7).
  3. Decision Based on Investigation:
    • Based on investigation findings, QA will decide whether to release or reject the material.
See also  SOP for Emergency Handling of Raw Material Storage Failures - V 2.0

5.5 Documentation and Record-Keeping

  1. Material Release Documentation:
    • Maintain complete records of all released materials, including test results, approval forms, and regulatory compliance documents.
  2. Material Rejection Documentation:
    • Maintain detailed records of all rejected materials, including reasons for rejection, investigation reports, and disposal plans.

5.6 Training and Compliance Monitoring

  1. Personnel Training:
    • All QA and QC personnel must be trained in material release and rejection procedures.
    • Document training in the Training Log (Annexure-8).
  2. Compliance Audits:
    • QA conducts periodic audits of release and rejection processes to ensure compliance with SOP and regulatory standards.
    • Document audit findings in the Compliance Audit Log (Annexure-9).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QA: Quality Assurance
  • QC: Quality Control
  • OOS: Out-of-Specification
  • APIs: Active Pharmaceutical Ingredients

7. Documents

  1. QC Test Result Log (Annexure-1)
  2. OOS Report (Annexure-2)
  3. Material Release Authorization Form (Annexure-3)
  4. Quarantine Release Log (Annexure-4)
  5. Material Rejection Authorization Form (Annexure-5)
  6. Quarantine Rejection Log (Annexure-6)
  7. OOS Investigation Report (Annexure-7)
  8. Training Log (Annexure-8)
  9. Compliance Audit Log (Annexure-9)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • WHO GMP Guidelines for the Pharmaceutical Industry

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

See also  SOP for Receiving of Raw Materials from Vendors - V 2.0

Annexure-1: QC Test Result Log

Date Material Name Batch Number Test Conducted Result Tested By
01/02/2025 API-X API-X-2025-001 Purity Test 98% Sunita Sharma

Annexure-2: OOS Report

Date Material Name Batch Number Description of OOS Reported By
02/02/2025 API-X API-X-2025-001 Purity Below Specification Ajay Singh

Annexure-3: Material Release Authorization Form

Date Material Name Batch Number Approved By Signature
03/02/2025 API-Y API-Y-2025-002 Anjali Mehta

Annexure-4: Quarantine Release Log

Date Material Name Batch Number Release Decision Released By
03/02/2025 API-Y API-Y-2025-002 Released QA Manager

Annexure-5: Material Rejection Authorization Form

Date Material Name Batch Number Rejected By Reason for Rejection
04/02/2025 API-X API-X-2025-001 Anjali Mehta Purity Below Specification

Annexure-6: Quarantine Rejection Log

Date Material Name Batch Number Rejection Decision Rejected By
04/02/2025 API-X API-X-2025-001 Rejected QA Manager

Annexure-7: OOS Investigation Report

Date Material Name Batch Number Investigation Findings Conclusion
05/02/2025 API-X API-X-2025-001 Supplier Process Issue Identified Material Rejected

Annexure-8: Training Log

Date Training Topic Trainer Attendee Name Signature
06/02/2025 Material Release and Rejection Procedures QA Manager Sunita Sharma

Annexure-9: Compliance Audit Log

Date Audit Type Findings Corrective Actions Audited By
07/02/2025 Material Release Compliance Audit Documentation Gaps Found Updated SOP for Documentation Accuracy Anjali Mehta

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated Material Release and Rejection Procedures Regulatory Compliance QA Head
Raw Material Warehouse V 2.0 Tags:Audit compliance in material storage, Contamination prevention in warehouses, Documentation in warehouse operations, Emergency procedures in warehouses, Equipment maintenance in warehouses, FIFO method in inventory, Handling of hazardous materials, Inventory management SOP, Labeling requirements in warehouses, Loading and unloading procedures, Material inspection protocol, Material receiving process, Material segregation guidelines, Pest control in storage areas, Quality control in warehousing, Raw material handling SOP, Return material handling SOP, Safety procedures for material handling, Security measures for stored materials, Spill response procedures, Storage conditions for raw materials, Temperature and humidity control in storage, Training for warehouse personnel, Warehouse storage procedures, Waste management in warehouses

Post navigation

Previous Post: Ointments: SOP for Real-Time Stability Monitoring – V 2.0
Next Post: Tablets: SOP for X-Ray Powder Diffraction for API Analysis in Tablets – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version